Rebollar-Rangel JA, Escobedo-Torres P, Flores-Nava G

Language: Spanish
References: 10
Page: 88-91
PDF size: 246.33 Kb.

ABSTRACT

Introduction: Neonatal jaundice is one of the main causes of admission to hospitals with pediatric care. It is a physiological process that usually does not require treatment. Objective: To determine the etiology of neonatal jaundice in patients in a General Hospital of Mexico City over a period of five years. Material and methods: 90 clinical records of patients admitted to hospital with a diagnosis of neonatal jaundice were reviewed. Clinical and demographic characteristics were analyzed and the cause of jaundice was investigated. Descriptive statistics was performed. Results: Male 52.2%, female 47.8%. Gestational age at birth 38 ± 1, birth weight 2,884 ± 461 grams, childbirth 73.5%, caesarean section 26.5%, age at hospitalization 4 ± 2 days, indirect bilirubin 18.69 ± 4.7 mg/dL, direct bilirubin 0.4 ± 0.2 mg/dL, phototherapy days 3 ± 1 days. Fourteen causes of jaundice were found, the five most frequent were physiologic jaundice 24.4%, incompatibility to group A 18.9%, and to group B 13.4%, neonatal sepsis 11.3% and low weight for gestation 10%. The incompatibility to group A or B together 32.2%. Conclusions: The main cause of neonatal jaundice admission was ABO incompatibility followed by physiologic jaundice, sepsis and low birth weight. The mean duration of phototherapy was three days.

REFERENCES

1. Cohen RS, Wong RJ, Stevenson DK. Understanding neonatal jaundice: a perspective on causation. Pediatr Neonatol. 2010; 51(3): 143-148.

2. Rennie J, Burman-Roy S, Murphy MS; Guideline Development Group. Neonatal jaundice: summary of NICE guidance. BMJ. 2010; 340: c2409.

3. Bhutani VK, Johnson LH. Urgent clinical need for accurate and precise bilirubin measurements in the United States to prevent kernicterus. Clin Chem. 2004; 50(3): 477-80.

4. Rodríguez-Miguélez JM, Figueras-Aloy J. Capítulo 38: Ictericia neonatal. En: Protocolos diagnóstico terapeúticos de la AEP: Neonatología. 2008. pp. 372-383. Disponible en: www.aeped.es/protocolos/

5. Geaghan SM. Diagnostic laboratory technologies for the fetus and neonate with isoimmunization. Semin Perinatol. 2011; 35(3): 148-154.

6. Rodríguez MCA, Rojas GSN, Ruiz RJI, Peñuela H. Prevalencia de ictericia neonatal patológica en el Servicio de Neonatología del Hospital Universitario Dr. Ángel Larralde, Valencia Estado Carabobo. Venezuela. Febrero 2012-abril 2012. Avances en Ciencias de la Salud. 2012; 2(1): 38-43.

7. Villegas-Cruz D, Durán-Menéndez R, Alfonso-Dávila A, López De Roux MR, Cortina L, Vilar-Carro M et al. Enfermedad hemolítica del recién nacido por incompatibilidad ABO. Rev Cubana Pediatr [Internet]. 2007; 79(4).

8. Navarro E, Mendieta E, Mir R, Céspedes E, Caballero BC. Readmisiones hospitalarias en recién nacidos egresados de una sala de alojamiento conjunto. Rev Chil Pediatr. 2008; 79(5): 553-553.

9. Keren R, Bhutani VK, Luan X, Nihtianova S, Cnaan A, Schwartz JS. Identifying newborns at risk of significant hyperbilirubinaemia: a comparison of two recommended approaches. Arch Dis Child. 2005; 90(4): 415-421.

10. Bhutani VK, Johnson LH, Schwoebel A, Gennaro S. A systems approach for neonatal hyperbilirubinemia in term and near-term newborns. J Obstet Gynecol Neonatal Nurs. 2006; 35(4): 444-455.